Literature DB >> 8106731

Epidemiology of genital herpes infections.

G J Mertz1.   

Abstract

Much has been learned in the last decade about the epidemiology of genital herpes infections, including new information about seroprevalence and the risk of transmission of genital herpes to sex partners and at delivery. Unfortunately, the type-specific serologic assays now routinely used in these studies are not widely available, and commercially available assays that claim to be type-specific are not. Thus, most clinicians still do not have access to reliable type-specific assays. In cross-sectional seroprevalence studies, detection of HSV-2 antibody is positively associated with increasing age, lower levels of income or education, increased numbers of sexual partners, black or Hispanic race, female gender, male homosexual activity, and HIV infection. In addition, studies cited in this review have clarified the clinical spectrum of genital herpes infection in persons who have transmitted genital herpes to a sex partner, have shed virus asymptomatically, or are found to have HSV-2 antibody. Ten percent to 40% of these individuals are aware that they have genital herpes, whereas the remaining 60% to 90% are not. Among the latter, at least half have a history of recurrent genital lesions typical of genital herpes or can be taught to recognize typical, symptomatic episodes within 6 months if examined promptly after the onset of any unexplained genital symptoms. The remainder, about a third of the total, have no history of genital herpes and remain asymptomatic despite a careful history and follow-up examinations; in women in this group, asymptomatic shedding of HSV can be identified. Atypical lesions appear to play an important but as yet incompletely defined role. Most persons who transmit genital herpes to a sex partner or at delivery do not have a history of lesions at the time of transmission of HSV infection, suggesting that asymptomatic shedding or atypical, unrecognized lesions are responsible for most cases of transmission. In heterosexual couples, the risk of acquisition of HSV-2 infection from a sex partner with genital herpes is lowest in men (less than 5%), higher in HSV-1 seropositive women (less than 10%), and highest (about 30%) in women without antibody to HSV-1 or HSV-2. The risk of transmission to infants exposed to asymptomatic shedding at delivery is low (about 3%) in women with or without a history of genital herpes if HSV antibody of the same type is present in cord blood.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8106731

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  9 in total

1.  Genital herpes, "the new paradigm".

Authors:  S Taylor; S Drake; D Pillay
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

2.  Viral diseases of the skin: diagnosis and antiviral treatment.

Authors:  Zoltan Trizna
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  The international development of the RGHQoL: a quality of life measure for recurrent genital herpes.

Authors:  L C Doward; S P McKenna; T Kohlmann; M Niero; D Patrick; B Spencer; H Thorsen
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

Review 4.  Drug therapies for sexually transmitted diseases. Clinical and economic considerations.

Authors:  W R Bowie
Journal:  Drugs       Date:  1995-04       Impact factor: 9.546

5.  Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States.

Authors:  Kristen C Peña; Martin E Adelson; Eli Mordechai; John A Blaho
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

6.  A case of maternal herpes simplex virus encephalitis during late pregnancy.

Authors:  Johann Sellner; Roberto Buonomano; Krassen Nedeltchev; Oliver Findling; Gerhard Schroth; Daniel V Surbek; Stephen L Leib
Journal:  Nat Clin Pract Neurol       Date:  2009-01

7.  Reconsideration of viral protein immunoblotting for differentiation of human herpes simplex viruses.

Authors:  Robert N Bowles; Jamie C Yedowitz; John A Blaho
Journal:  Diagn Microbiol Infect Dis       Date:  2008-07-17       Impact factor: 2.803

8.  Clinical and Laboratory Findings That Differentiate Herpes Simplex Virus Central Nervous System Disease from Enteroviral Meningitis.

Authors:  Layli Sanaee; Monica Taljaard; Tim Karnauchow; Jeffrey J Perry
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-08-01       Impact factor: 2.471

9.  Remoteness influences access to sexual partners and drives patterns of viral sexually transmitted infection prevalence among nomadic pastoralists.

Authors:  Ashley Hazel; James Holland Jones
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.